# OnCo record seven-plus-three (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/seven-plus-three/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "seven-plus-three" ;
  schema:name "7+3 induction chemotherapy"@en ;
  schema:alternateName "7+3"@en, "7 + 3"@en, "cytarabine-anthracycline"@en, "cytarabine plus daunorubicin"@en, "intensive chemotherapy"@en, "intensive induction"@en, "non-intensive"@en, "non-intensive therapy"@en, "less intensive"@en, "CPX-351"@en, "Vyxeos"@en, "HiDAC"@en, "high-dose cytarabine"@en, "FLAG-IDA"@en ;
  schema:description "The classic first treatment for acute myeloid leukaemia, unchanged since 1973: seven days of continuous cytarabine plus three days of an anthracycline, given in hospital. Fit patients still get it, now with a targeted drug added according to their leukaemia's genetics."@en ;
  schema:url <https://onco.cc/terms/seven-plus-three/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Acute_myeloid_leukemia#Treatment> ;
  schema:citation <https://en.wikipedia.org/wiki/Acute_myeloid_leukemia#Treatment> ;
  onco:related <https://onco.cc/terms/induction-therapy/>, <https://onco.cc/terms/anthracycline/>, <https://onco.cc/terms/hma/>, <https://onco.cc/terms/allogeneic-transplant/> ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/azacitidine/>, <https://onco.cc/drugs/midostaurin/>, <https://onco.cc/drugs/gilteritinib/> .